LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β

Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC), especially in BRAF‐like PTC, by analyzing The Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wei‐Jun, Zhu, Liu‐Lian, Yang, Wei‐Qiang, Xu, Shuai‐Jun, Chen, Jie, Ding, Xiao‐Fei, Liang, Yong, Chen, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019227/
https://www.ncbi.nlm.nih.gov/pubmed/33540491
http://dx.doi.org/10.1111/cas.14837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019227/
https://www.ncbi.nlm.nih.gov/pubmed/33540491
http://dx.doi.org/10.1111/cas.14837

Ejemplares similares